Considerable evidence suggests that psychostimulants can exert rewarding and locomotor-stimulating effects via increased dopamine transmission in the ventral striatum. However, the relative contributions of ventral striatal subregions to each of these effects have been little investigated. In the present study, we examined the contribution of different ventral striatal sites to the rewarding and locomotor-activating effects of cocaine. Initially, the effects of bilateral 6-hydroxydopamine lesions of the nucleus accumbens core or medial shell on cocaine-induced locomotor stimulation (0.5-1.5 mg/kg i.v. or 5-20 mg/kg i.p.) and conditioned place preference (0.5 mg/kg i.v. or 10 mg/kg i.p.) were examined. In a subsequent study, we investigated the effects of olfactory tubercle versus medial shell lesions on cocaine-conditioned place preference and locomotor activity (0.5 mg/kg i.v.). Dopaminergic lesion extent was quantified by radioligand binding to the dopamine transporter. Multiple linear regression was used to identify associations between behavioral effects and residual dopamine innervation in ventral striatal subregions.
tor activity (0.5 mg/kg i.v.). Dopaminergic lesion extent was quantified by radioligand binding to the dopamine transporter. Multiple linear regression was used to identify associations between behavioral effects and residual dopamine innervation in ventral striatal subregions. On this basis, the accumbens core was associated with the locomotor stimulant effects of i.v. and i.p. cocaine. In contrast, the medial shell was associated with the rewarding effect of i.v. cocaine, but not of i.p. cocaine. Finally, the olfactory tubercle was identified as an additional site contributing to conditioned place preference produced by i.v. cocaine. Overall, these findings provide additional evidence that the locomotor stimulant and rewarding effects of systemically administered psychomotor stimulant drugs are segregated within the ventral striatum.
The nucleus accumbens (NAcc) plays an important role in the rewarding and locomotor stimulant effects of systemically administered amphetamine and cocaine (Koob et al., 1998; Everitt and Wolf, 2002; Wise, 2004) . It is anatomically and neurochemically heterogeneous, with a prominent medioventral shell and dorsolateral core (Zahm and Brog, 1992) . Recent behavioral studies, largely relying on intracranial microinjections of dopaminergic agonists, have provided evidence for functional compartmentalization within this structure, although certain details are controversial. Thus, the medial shell subregion has been implicated in reward processes (Di Chiara et al., 2004; Ikemoto and Wise, 2004) , whereas locomotor stimulation has been elicited from core and/or shell injection sites (Boye et al., 2001; Ikemoto, 2002; Sellings and Clarke, 2003, and references therein) .
The technique of intracranial drug microinjection, despite its obvious utility, is limited by the fact that local drug concentrations are usually unknown and may not be comparable with those obtained after systemic administration. Using an alternate approach, we recently evaluated the respective roles of accumbens core and shell in amphetamineinduced locomotion and conditioned place preference (CPP) by combining a systemic amphetamine challenge with prior 6-hydroxydopamine (6-OHDA) lesions of either structure (Sellings and Clarke, 2003) . In this study, DAergic depletion in core and medial shell reduced amphetamine-induced locomotor stimulation and CPP, respectively.
In the present study, we sought to extend these findings to cocaine. Intra-NAcc infusion of cocaine produces both locomotor stimulation and rewarding effects (Ikemoto, 2002 (Ikemoto, , 2003 Rodd-Henricks et al., 2002; Ikemoto and Witkin, 2003) . However, the interpretation of such findings is complicated by possible sympathomimetic and anesthetic actions within the target tissue (Ikemoto, 2003; Ikemoto and Witkin, 2003) . Even after systemic injection, the precise route of administration can be critical. In particular, cocaine is reported to produce dopamine (DA)-dependent or DA-independent rewarding effects, depending on whether it is delivered i.v. or i.p. (Spyraki et al., 1987) . In the present study, these two systemic routes of administration were compared.
The less-studied olfactory tubercle (OT) may also play a role in psychomotor stimulant-mediated locomotor activation and reward. This is suggested by studies using intracranial administration in rats. Thus, direct intra-OT infusions of DA agonists including amphetamine and cocaine produced marked and prompt locomotor activation (Pijnenburg et al., 1976; Cools, 1986; Ikemoto, 2002) , and both these drugs were avidly self-administered at OT sites (Ikemoto, 2003; . Interestingly, intra-OT drug infusions elicited stronger locomotor and reinforcing effects than intra-NAcc infusions (Cools, 1986; Ikemoto, 2003; . Despite these positive findings, we previously tested the impact of profound 6-OHDA lesions of OT on the locomotor stimulant and rewarding (CPP) effects of systemic amphetamine challenge and concluded that DAergic transmission in the OT does not contribute significantly to either behavioral effect (Clarke et al., 1988 (Clarke et al., , 1990 . Hence, at present, it is an open question whether the OT contributes significantly to the locomotor stimulant and rewarding effects of any systemically administered psychostimulant.
The overall goal of the present study was, therefore, to localize the ventral striatal actions of systemically administered cocaine. The first experiment investigated whether the locomotor stimulant effects of i.v. and i.p. cocaine are diminished by DA denervation in the accumbens core or medial shell. The next two experiments determined whether the stimulant and rewarding effects of cocaine could be dissociated by selective 6-OHDA lesions of either structure, as previously seen with amphetamine (Sellings and Clarke, 2003 ). The final experiment tested for OT involvement in cocaine reward and locomotor activation, again after systemic drug challenge.
Materials and Methods
Experimental Design. The design of all four experiments is summarized in Table 1 .
Subjects. Subjects were male Long-Evans rats (Charles River, St. Constant, QC, Canada) weighing 250 to 325 g at the time of surgery. Rats were housed individually (experiment 1) or in groups of three (experiments 2-4) in clear Plexiglas cages in a temperature-and humidity-controlled animal colony, lit from 7:00 AM to 7:00 PM. Food and water were available ad libitum except during behavioral testing. All experiments were approved by the McGill Faculty of Medicine Animal Care Committee in accordance with Canadian Council on Animal Care guidelines.
Stereotaxic Infusion of 6-OHDA. Surgery was performed 7 to 10 days before the start of behavioral testing. Rats were anesthetized with ketamine HCl (90 mg/kg i.p.) and xylazine HCl (16 mg/kg i.p.) before placement in a stereotaxic apparatus (David Kopf Instruments, Tujunga, CA) with the incisor bar set at Ϫ3.9 mm. Depending on the experiment (see Table 1 ), rats received bilateral infusions of either 6-OHDA or vehicle into either NAcc core, medial shell, or anteromedial olfactory tubercle (amOT). Infusions were made via a 30 gauge stainless steel cannula attached by polyethylene tubing to a 10-l Hamilton syringe driven by a model 5000 Micro Injection Unit (David Kopf Instruments) (core or medial shell) or via two separate 10-l Hamilton syringes driven by a multichannel syringe pump (amOT; MD-1001, BAS Bioanalytical Systems Inc., West Lafayette, IN). For greater accuracy, coordinates for all three target subregions were derived from the mean of two coordinate systems. Thus, anterior-posterior coordinates were ϩ10.3 mm from interaural zero and ϩ1.3 mm from bregma for both core and shell and ϩ10.7 mm from interaural zero and ϩ1.7 mm from bregma for amOT. Lateral coordinates were Ϯ0.6 mm (shell), Ϯ2.4 mm (core), and Ϯ0.8 mm (amOT). Ventral coordinates for shell (three injections) were ϩ2.0, ϩ2.4, and ϩ2.8 mm from interaural zero and Ϫ8.0, Ϫ7.6, and Ϫ7.2 mm from bregma. Ventral coordinates for core were ϩ2.7 mm from interaural zero and Ϫ7.3 mm from bregma. For amOT, ventral coordinates were ϩ1.1 and Ϫ8.9 mm, respectively, from interaural zero and bregma. All coordinates are based on the atlas of Paxinos and Watson (1997) . 6-OHDA or vehicle was infused on each side in a volume of 0.1 l (core), as three infusions of 0.06 l (medial shell) or 0.2 l (amOT) on each side. For core and medial shell, 6-OHDA was infused at a rate of 0.1 l/min; for amOT, the rate of infusion was 0.1 l/10 min. The concentration of 6-OHDA used was 80 g/l (core) or 48 g/l (shell). For amOT, a volume of 0.2 l of either vehicle or 6-OHDA (40 g/l free base) was infused bilaterally over 20 min. The different doses of 6-OHDA, infusion volumes, and infusion times used at each lesion site were chosen based on pilot studies and represented the best compromise between efficacy (DA depletion) and anatomical selectivity. For all three lesion sites, the cannula remained at the final infusion site for 5 min.
Intravenous Catheterization. During 6-OHDA lesion surgery, rats were implanted with chronic indwelling Silastic catheters (0.51 mm i.d. and 0.94 mm o.d., Fisher Scientific, Montreal, QC, Canada) in the left jugular vein. Tubing was secured to the vein by surgical silk sutures, was led s.c. to the skull surface, and was then fitted onto a 22-gauge cannula attached to a plastic connector (model number C313G-5UP; Plastics One, Roanoke, VA). The cannula/connector was fixed to the animal's skull with small stainless steel screws (Lomir, Notre-Dame-de-L'Ile Perrot, QC, Canada) and dental cement (Stoelting, Wood Dale, IL). To keep catheters patent, 0.1-to 0.15-ml heparinized 0.9% saline was administered at the end of surgery, on the first day of behavioral testing, and every 2 to 3 days thereafter.
Locomotor Activity Testing (Experiment 1). Horizontal locomotor activity was tested in the CPP apparatus (see below for description). Rats were first given one pre-exposure session (20 min) in 3, and 4) . The apparatus and general procedure were as described previously (Sellings and Clarke, 2003) . In brief, the procedure consisted of three phases: pre-exposure (1 day), conditioning (6 days), and test (1 day). All phases were carried out in a one-compartment box (58 cm ϫ 29 cm ϫ 53 cm) with walls made of white plastic-coated particle board. In the pre-exposure phase, Beta-Chip sawdust bedding covered the floor of the cage. In the conditioning phase, two square tactile tiles of either bar or mesh texture were placed in the bottom of the cage, on top of the bedding. During this phase, video tracking software (EthoVision version 3.0; Noldus Information Technology, Leesburg, VA) measured locomotor activity, expressed as horizontal distance moved (in meters). During the test phase, one bar and one mesh tile were placed on the bottom of the cage. The time spent on bar or mesh texture was measured by EthoVision software. All three phases were carried out under darkroom lighting using a Kodak GBX-2 safelight filter (Vistek, Toronto, ON, Canada), to minimize visual cues. Animals do not spontaneously prefer either texture (L. H. L. Sellings and P. B. S. Clarke, unpublished data) , and all experiments were as fully counterbalanced as possible with respect to drug-texture pairing and order of drug pairing (drug-saline or saline-drug) within each surgery group. For all experiments, pre-exposure sessions lasted 20 min, and the test session lasted 10 min. Conditioning trial duration for i.v. cocaine was 15 min and for i.p. cocaine was 25 min.
For i.v. infusion (experiments 1, 2, and 4), a fluid swivel was fixed above the center of each cage. Each swivel was connected on one end to a 1-ml syringe and on the other end to a brass connector (Produits MSM, Laval, QC, Canada) and a protective spring (Heiplex, Montreal, QC, Canada) via Tygon tubing of 0.51-mm diameter. The cannula fixed to the skull of the rat was attached to the Tygon tubing, and the brass connector was fastened to the plastic connector to secure the tubing to the cannula, hence allowing administration of drug immediately after placement of the animal in the CPP cage. Drug was infused over 25 to 30 s. Cocaine administered i.p. was injected immediately before placement in the CPP cage.
Tissue Preparation. Tissue was prepared for autoradiography and Nissl staining (Cresyl violet) as described previously (Sellings and Clarke, 2003) . In brief, rats were sacrificed 3 to 5 h after CPP testing by decapitation under sodium pentobarbital (65 mg/kg i.p.) anesthesia. Brains were removed, frozen in 2-methylbutane at Ϫ50°C for 30 s, and stored at Ϫ40°C.
Coronal sections (20 m) were taken on a cryostat at several rostrocaudal levels through the ventral striatum. In experiments 1, 2, and 3, sections were examined at 11.2, 10.7, 10.2, and 9.7 mm anterior to interaural zero; 9.2 and 8.7 mm were also examined in experiment 4 (Paxinos and Watson, 1997) . Four adjacent sections were collected for autoradiography and one for Nissl staining with Cresyl violet. Sections were thaw mounted onto gelatin-subbed slides, air-dried at room temperature for 20 to 30 min, and stored with desiccant at Ϫ40°C.
Quantitative Autoradiography. The extent and chemical selectivity of the 6-OHDA lesion was quantified by autoradiographic labeling of the DA transporter (DAT) and the 5-hydroxytryptamine (serotonin) transporter (SERT) (Sellings and Clarke, 2003) , using a nonsaturating concentration of [
125 I]3␤-(4-iodophenyl)tropan-2-␤-carboxylic acid methyl ester ([ 125 I]RTI-55) (2200 Ci/mmol; NENMandel, Guelph, ON, Canada).
Sections were thawed at room temperature for 10 min and then placed in a staining dish containing an aqueous buffer solution of 120 mM NaCl, 0.1 M sucrose, 10 mM sodium phosphate buffer, and 10 pM [ 125 I]RTI-55, with the pH adjusted to 7.4. In the DAT autoradiographic assay, 50 nM citalopram hydrobromide was used to occlude SERT; nonspecific binding was determined by addition of 10 M 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine dihydrochloride (GBR 12909). For SERT autoradiography, 1 M 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride (GBR 12935) was added to occlude DAT; nonspecific binding was determined by addition of 50 nM citalopram HBr (Sellings and Clarke, 2003) . Slides were incubated at room temperature for 2 h and then washed three times in ice-cold buffer solution (once for 1 min and twice for 20 min) and for 1 to 2 s in distilled and deionized water. They were then blow-dried and placed in X-ray film cassettes. Kodak BioMax MS film (Amersham Biosciences, Baie d'Urfé, QC, Canada) was exposed to slides for 48 h (DAT) or 120 h (SERT) with 125 I autoradiographic standards (Amersham Biosciences). After development of film, DAT and SERT binding were quantified using an MCID M4 imaging system (Imaging Research, St. Catherines, ON, Canada).
Histological Examination. Tissue was stained with cresyl violet to assess nonspecific damage, as described previously (Sellings and Clarke, 2003) Cocaine HCl was dissolved in sterile 0.9% saline and injected at 1 ml/kg (i.v. or i.p.). 6-OHDA HBr was dissolved in sterile 0.9% saline containing 0.3 mg/ml sodium metabisulfite (Sigma-Aldrich) as an antioxidant and protected from light. Vehicle solutions as well as 6-OHDA to be infused into the medial shell or amOT were neutralized to pH 7.3 Ϯ 0.1 with NaOH (to reduce nonspecific damage; see Results). Doses of all drugs except 6-OHDA HBr are expressed as the salt. 6-OHDA HBr doses are expressed as free base.
Data Analysis. A commercial software program (Systat v10.2; SPSS Inc., Chicago, IL) was used for all data analyses. In all experiments, locomotor responses to cocaine were calculated as the difference of locomotor counts between drug and saline conditioning sessions. In CPP experiments, saline locomotor scores were calculated as the mean activity over all three conditioning sessions with saline and are expressed as means Ϯ S.E.M. After initial data inspection, sham groups were combined within each experiment. Group differences were analyzed by one-way analysis of variance. CPP magnitude was calculated as the difference between time spent on the drug-paired and vehicle-paired sides during the 10-min test session. Experiments 2 and 4 were each carried out in different batches because of space constraints in the animal facility; after initial data inspection, the results within each experiment were pooled. The existence of a significant CPP magnitude or locomotor stimulant effect was determined by a one-sample Student's t test with the Bonferroni correction for multiple comparisons. The relationship between behavioral measures versus [
125 I]RTI-55 labeling was analyzed by multiple linear regression. A p value of Ͻ0.05 (two-tailed) was considered significant. Group data are expressed as means Ϯ S.E.M. throughout.
6-OHDA in the core subregion (not shown). Among rats lesioned in the medial shell or amOT, most (ϳ60%) also showed a minimal degree of cell loss, ϳ30% of rats possessed a small region of decreased cell density at the infusion site (Fig. 1B) , and ϳ10% of rats showed more pronounced nonselective damage (Fig. 1C) . This larger region of nonspecific damage did not extend more than 0.3 mm from the site of infusion and was almost always found at only one anterior-posterior level.
Sampling locations for DAT and SERT binding density are indicated in Fig. 2. [
125 I]RTI-55 autoradiographs of DAT binding are shown in Fig. 3 . Residual DAT binding as a percentage of combined sham groups is given in Tables 2 (experiments 1-3) and 3 (experiment 4). Radioligand binding to SERT in tissue from lesioned animals was minimally changed by all lesion parameters in all experiments (Tables  2 and 3 ). In all experiments, rats were allowed 7 to 10 days recovery postsurgery before the start of behavioral testing.
The (Fig. 4, A and B) . The locomotor stimulant effects of cocaine were blunted only in the core-lesioned group. Multiple linear regression analysis revealed significant positive associations between core DAT binding and the locomotor stimulant response for both administration routes used and at all doses except for 0.5 mg/kg i.v. (range p Ͻ 0.001-p Ͻ 0.05). Significant negative associations were observed between medial shell DAT binding and the locomotor stimulant response at several cocaine doses (1 mg/kg i.v. and 5 and 10 mg/kg i.p.; p Ͻ 0.05-p Ͻ 0.005). Fig. 1 . Representative photomicrographs of Nissl staining in sham-lesioned (A) and amOT-lesioned (B and C) animals adjacent to the infusion site. In some (30%) of amOT-lesioned rats, a small region of reduced cell density was observed compared with sham-lesioned rats (B, black arrow). Larger regions of decreased cell density were seen in a subset (ϳ10%) of lesioned animals (C, black arrow). Scale bar, 100 m. ac, anterior commissure; Tu, medial olfactory tubercle. 
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The effects of core and medial shell 6-OHDA lesions on cocaine-induced locomotion were also tested in two CPP experiments (i.e., experiments 2 and 3). Locomotor data were obtained from the three drug and saline conditioning sessions. Experiment 2 examined the locomotor stimulant response to cocaine (0.5 mg/kg i.v.). Here, saline locomotor scores did not differ significantly among groups and were as follows: 52 Ϯ 2 m (sham), 54 Ϯ 2 m (core 6-OHDA), and 55 Ϯ 2 m (medial shell 6-OHDA). A significant locomotor stimulant effect was observed in sham-lesioned and medial shelllesioned animals, but not in the core-lesioned subjects (Fig.  5A) . Multiple linear regression analysis revealed a positive trend between the locomotor response and DAT binding in the core (p ϭ 0.086; Fig. 5B ) but not medial shell (Fig. 5C) .
The locomotor stimulant response to i.p. cocaine (10 mg/kg) was also attenuated after core 6-OHDA lesions (experiment 3; Fig. 6A ). No significant group differences were seen for saline locomotor activity. Saline scores were 85 Ϯ 6 (sham), 88 Ϯ 5 (core 6-OHDA), and 87 Ϯ 5 (medial shell 6-OHDA). Multiple linear regression analysis (Fig. 6 , B and C) revealed a positive association between the locomotor response and core DA innervation only (p Ͻ 0.05).
NAcc Medial Shell Lesions Inhibited CPP for Intravenous Cocaine. In experiment 2, only the combined sham group and the core-lesioned group exhibited significant CPP (Fig. 5D) . Relationships between the CPP magnitude and core versus medial shell DAT binding are shown in Fig. 5 , E and F, respectively. The CPP magnitude produced by i.v. cocaine was positively related to medial shell DAT binding (p Ͻ 0.005; Fig. 5F ) with a negative trend in the accumbens core (p ϭ 0.062; Fig. 5E ).
Conditioned Place Preference for Intraperitoneal Cocaine Was Unaffected by Lesions of Core or Medial
Shell. In experiment 3, a significant CPP to i.p. cocaine occurred in the sham-lesioned group, with a similar trend in the two lesion groups (Fig. 6D ). No significant relationship was observed between the CPP magnitude and core or medial shell DAT binding (Fig. 6, E and F) .
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Infusions of 6-OHDA into either amOT or medial shell depleted DAT binding locally and also tended to produce a smaller and variable depletion in the other structure (Fig. 7) . Initial analysis revealed a high degree of colinearity existing in DAT binding levels between different OT subregions. Accordingly, these values were averaged, and subsequent analyses were carried out using OT rather than amOT values.
Only sham-lesioned animals exhibited significant CPP (Fig. 8A) . Multiple linear regression analysis was performed with CPP magnitude as the dependent variable, using residual DAT binding in core, medial shell, ventral shell, ventral caudate putamen, and OT as simultaneous predictors. Only OT was retained as a significant predictor (p Ͻ 0.01) (Fig.  8C) . Linear regression analysis of CPP magnitude with medial shell as the sole predictor revealed a positive association that bordered on significance (p ϭ 0.056). Linear regression analysis of the locomotor stimulant effect revealed that DAT binding in neither medial shell nor OT predicted the degree of locomotor stimulation (p Ͼ 0.5 for both, data not shown).
Discussion
Novel Findings. To our knowledge, the present study is the first to examine the role of ventral striatal subregions in CPP induced by systemically administered cocaine. Cocaine-induced locomotion was related to core DA innervation at several doses of both i.v. and i.p. cocaine. CPP results, in contrast, were more complex. Intravenous cocaine CPP appeared to be dependent on DA innervation in both OT and medial shell, whereas i.p. cocaine CPP was unaffected by medial shell lesions.
Methodological Considerations. The present series of experiments revealed associations between residual DA innervation in various ventral striatal structures and cocaineinduced locomotion or CPP. It is doubtful that these relationships represent segregation between conditioned and unconditioned drug effects rather than between reward and locomotion, as core but not medial shell 6-OHDA lesions abolished amphetamine-induced conditioned locomotion (Sellings and Clarke, 2006) .
In the present study, quantitative autoradiographic analysis was performed by taking a large number of samples within each structure (e.g., 24 each for medial shell and core). Within each targeted structure, the extent of DAT depletion appeared rather uniform (see Fig. 3 and Sellings and Clarke, 2003) , and visual inspection revealed no evidence for smaller sites of preferential depletion. Nevertheless, we cannot rule out the possibility that our behavioral effects resulted from damage to functionally important "hot spots" within the targeted structures.
It is unlikely that nonspecific damage caused these lesion effects, since only minimal changes were observed in SERT binding levels, and Nissl staining revealed only slight nonspecific damage in a subset of medial shell-and medial OTlesioned animals (Fig. 1) . However, 6-OHDA infusion almost certainly depleted noradrenaline as well as DA. Preservation of noradrenergic terminals by using systemic desipramine proved impossible, since in pilot studies the routinely used dose of 25 mg/kg (Kelly and Iversen, 1976 ) caused significant mortality (Ͼ25%). Nevertheless, for several reasons, it is unlikely that the observed lesion effects were due to loss of noradrenergic terminals. First, neither noradrenergic agonists nor antagonists, when injected into ventral striatum, affected locomotion (Pijnenburg et al., 1975 (Pijnenburg et al., , 1976 . Second, noradrenergic denervation of ventral striatum does not alter locomotor stimulant responses to cocaine and amphetamine (Roberts et al., 1975; Kelly and Iversen, 1976) . Third, noradrenergic afferents to NAcc largely avoid the core (Delfs et al., 1998) , where lesion effects on locomotor stimulation oc- jpet.aspetjournals.org curred. Fourth, stimulation of noradrenergic transmission did not produce CPP (Martin-Iverson et al., 1985; Subhan et al., 2000) . Fifth, neither ␣-nor ␤-adrenergic receptor antagonists affected the rewarding effects of i.v. cocaine as reflected by self-administration behavior (Johanson and Fischman, 1989) . Sixth, the disruptive effects of 6-OHDA lesions on cocaine self-administration appear to be unrelated to noradrenaline depletion (Roberts et al., 1975 (Roberts et al., , 1977 . Lastly, self-administration of cocaine directly into the amOT was blocked by coinfusion of a D1 or D2 DA receptor antagonist (Ikemoto, 2003) . On this basis, it seems reasonable to conclude that our 6-OHDA lesions produced their behavioral effects via local depletion of DA.
The Accumbens Core and Locomotor Activation. There is currently no consensus on the role of core versus shell in psychostimulant-induced locomotion (Boye et al., 2001; Ikemoto, 2002, and references therein) . In particular, studies with intra-accumbens microinjection of direct or indirect DAergic agonists have implicated core, shell, or both structures, depending on the drug. For example, amphet- amine acted with similar potency at either injection site, whereas cocaine stimulated locomotor activity most strongly after injection into medial OT and medial shell (Ikemoto, 2002) . Importantly, locomotor responses from accumbens core injections of cocaine may have been weakened by local anesthesia (Ikemoto and Witkin, 2003) .
The present experiments show that the locomotor stimulant effects of systemically administered cocaine are associated with DAergic neurotransmission in core rather than medial shell. This result generalized to several doses of the drug and to both i.p. and i.v. routes of administration. These findings accord with observations using systemic amphetamine (Boye et al., 2001; Sellings and Clarke, 2003 , and references therein) and methylphenidate (L. H. L. Sellings, L. E. McQuade, and P. B. S. Clarke, manuscript submitted for publication). Taken together, they suggest a general mechanism by which systemically administered psychostimulants produce activating effects. Whether core DA transmission directly mediates the locomotor stimulant action of these drugs or plays an indirect enabling role remains a question for the future.
Differences between Intraperitoneal and Intravenous Cocaine CPP. In the present study, i.v. cocaine produced CPP that appears to be dependent on DA transmission Fig. 6 . Effect of bilateral 6-OHDA infusion into either NAcc core or medial shell on locomotor response and CPP to i.p. cocaine (experiment 3). Rats were conditioned with i.p. cocaine (10 mg/kg). Data are presented as in Fig. 3 . All groups exhibit significant locomotor stimulation (A), but that of corelesioned animals was smaller than that of the shamand shell-lesioned groups (p Ͻ 0.05). Only sham rats exhibited significant CPP, but core-and shell-lesioned animals also tended to exhibit CPP (D). Locomotor response correlated positively and significantly with DAT binding in core (B) . No other behavioral responses correlated with DAT labeling in either structure (C, E, and F). CV, core vehicle; CL, core-lesioned; SV, medial shell vehicle; SL, medial shell lesion. Shell refers to medial shell.
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at ASPET Journals on April 1, 2017 jpet.aspetjournals.org in both medial shell and OT. In contrast, i.p. cocaine CPP did not appear to be dependent on accumbens DA transmission. This finding is consistent with reports suggesting that i.v. cocaine produces DA-dependent CPP and i.p. cocaine produces DA-independent CPP (Morency and Beninger, 1986; Spyraki et al., 1987) . Although neuroadaptation may account for the lack of lesion effect on i.p. cocaine CPP, this appears unlikely considering the fact that similar medial shell lesions reduced CPP both for i.v. cocaine and for amphetamine (Sellings and Clarke, 2003) . Our results do not rule out other forms of accumbens involvement; indeed glutamatergic and serotonergic manipulations within this structure affect i.p. cocaine CPP (Kaddis et al., 1995; Harris et al., 2001) .
Because cocaine produces CPP more potently after i.v. than after i.p. administration (Spyraki et al., 1987; O'Dell et al., 1996) , care was taken in the present study to select submaximal i.p. and i.v. doses of cocaine approximately matched in terms of CPP magnitude. Hence, it is likely that the differential sensitivity to DA depletion reflected route of administration and not dose.
The neurochemical basis of this differential susceptibility cannot readily be related to changes in extracellular DA. The i.v. dose used (0.5 mg/kg) has been reported to increase dialysate DA levels in the medial shell but not the core (Pontieri et al., 1995) , whereas the i.p. dose (10 mg/kg) robustly increased DA levels in both subregions (Cadoni et al., 2000) . Another reported difference between i.v. and i.p. cocaine administration is that only the former caused significant increases in glucose metabolism in NAcc and OT (Porrino, 1993) ; in the latter study, the use of a wide range of doses suggests strongly that route of administration was the critical factor. The basis for route-dependent effects on cerebral glucose utilization and the possible relation to cocaine reward remain to be elucidated.
Cocaine CPP: Dependence on Both Medial Shell and OT. Although there is a rich body of literature linking the NAcc to drug reward, possible OT involvement has been largely unexamined (Clarke et al., 1990; Kornetsky et al., 1991; Ikemoto, 2003; Ikemoto and Donahue, 2005) . The present results suggest that both medial shell and OT play important roles in mediating i.v. cocaine reward.
Self-administration of cocaine directly into the ventral striatum appears strongly site-dependent; responding was vigorous for infusions into amOT, marginal in medial shell, and negligible within accumbens core (Rodd-Henricks et al., 2002; Ikemoto, 2003) . In addition, only cocaine infusion at amOT sites produced CPP at the doses tested (Ikemoto, 2003) . However, the behavioral effects of focal cocaine infusion into the NAcc (shell or core) may be masked by local anesthesia (Ikemoto and Witkin, 2003) . Nevertheless, DA antagonist microinjection experiments suggest that it is the medial shell rather than the core that mediates the reinforcing effects of self-administered i.v. cocaine (Bari and Pierce, 2005) .
In experiment 2, lesions of the medial shell reduced i.v. cocaine CPP independently of accumbens core; in this experiment, DA denervation in the OT was minimal. When 6-OHDA infusions of medial shell and OT were directly compared (experiment 4), only OT DA innervation significantly predicted i.v. cocaine CPP. These results may indicate that the OT is a stronger mediator of cocaine reward, as concluded from findings based on intracranial cocaine infusion (Ikemoto, 2003) . It is unlikely that these lesion effects represent disruptions of memory or learning, as medial shell lesions did not affect CPP induced by morphine (Sellings and Clarke, 2003) or i.p. cocaine (present study), and extensive 6-OHDA lesions of OT did not disrupt amphetamine CPP (Clarke et al., 1990) .
Several factors could determine the relative contributions of OT versus medial shell to psychostimulant CPP. First, the nature of the CPP paradigm used may be a factor. Our CPP procedure is based on tactile cues; other types of stimuli may engage other ventral striatal subregions. Another factor of potential importance is the drug in question. Our results suggest that i.v. cocaine CPP engages OT mechanisms. This does not appear to be the case for i.p. amphetamine CPP (Clarke et al., 1990) .
Conclusions
The increase in locomotor activity observed after psychostimulant administration appears to be related to increased DA transmission in the NAcc core. In contrast, CPP appears more complex, probably depending on the drug and route of administration. The present study suggests that DA transmission in both medial shell and OT is important for i.v. cocaine CPP. Our findings build on recent evidence suggesting that distinct ventral striatal subregions participate in different aspects of drug reward (Ikemoto, 2003; Sellings and Clarke, 2003; Ikemoto and Donahue, 2005; Pecina and Berridge, 2005) . Whether these structures act in concert or independently remains a question for further study (van Dongen et al., 2005) .
